PE20140406A1 - Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humana - Google Patents
Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humanaInfo
- Publication number
- PE20140406A1 PE20140406A1 PE2013001206A PE2013001206A PE20140406A1 PE 20140406 A1 PE20140406 A1 PE 20140406A1 PE 2013001206 A PE2013001206 A PE 2013001206A PE 2013001206 A PE2013001206 A PE 2013001206A PE 20140406 A1 PE20140406 A1 PE 20140406A1
- Authority
- PE
- Peru
- Prior art keywords
- immunodeficiency virus
- human immunodeficiency
- against human
- bifunctional molecules
- inhibitory activity
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 230000001588 bifunctional effect Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000007115 recruitment Effects 0.000 title 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001721 carbon Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
REFERIDA A UN COMPUESTO HETEROCICLICO DE FORMULA (A), DONDE ABT ES UN EXTREMO DE UNION A ANTICUERPO QUE COMPRENDE UN HAPTENO; LINKER ES UNA MOLECULA ENLAZADORA LA CUAL ENLAZA QUIMICAMENTE ABT A RY O DIRECTAMNETE AL GRUPO INDOL EN EL ATOMO DE CARBONO AL CUAL RY SE ENCUENTRA UNIDO; ARYL ES UN GRUPO AROMATICO O HETEROAROMATICO; RY ES O, NHC(O)NH, S(O)2O, ENTRE OTROS; X2 ES H, (CH2)nOH, (CH2)nCOOH, ENTRE OTROS; X3 ES H, (CH2)nOH, (CH2)nCOOH, ENTRE OTROS; R1 ES H O ALQUILO C1-C3; i ES 0 O 1; k ES 0, 1, 2 O 3; n ES 0 O UN ENTERO DE 1 A 6; Y3 ES H O ALQUILO C1-C3; RN ES H O ALQUILO C1-C3 OPCIONALMENTE SUSTITUIDO CON O O HALOGENO. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DEL VIH
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41497710P | 2010-11-18 | 2010-11-18 | |
US201161522518P | 2011-08-11 | 2011-08-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20140406A1 true PE20140406A1 (es) | 2014-04-16 |
Family
ID=46084646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2013001206A PE20140406A1 (es) | 2010-11-18 | 2011-11-17 | Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humana |
Country Status (16)
Country | Link |
---|---|
US (5) | US9562038B2 (es) |
EP (1) | EP2640720B1 (es) |
JP (2) | JP6155193B2 (es) |
KR (1) | KR20140000275A (es) |
CN (2) | CN107011333B (es) |
AU (1) | AU2011329829B2 (es) |
BR (1) | BR112013012309A2 (es) |
CA (1) | CA2818308A1 (es) |
CL (1) | CL2013001429A1 (es) |
CO (1) | CO6801635A2 (es) |
EA (1) | EA201390726A1 (es) |
IL (1) | IL226397B (es) |
MX (1) | MX350974B (es) |
PE (1) | PE20140406A1 (es) |
SG (2) | SG10201510402WA (es) |
WO (1) | WO2012068366A2 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2206702T3 (da) | 2001-08-08 | 2012-02-13 | Tobira Therapeutics Inc | Bicyklisk forbindelse, fremstilling og anvendelse deraf |
WO2011046946A2 (en) * | 2009-10-13 | 2011-04-21 | Yale University | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
SG10201510402WA (en) | 2010-11-18 | 2016-01-28 | Univ Yale | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
US20140308342A1 (en) | 2011-11-11 | 2014-10-16 | Yale University | Reprogramming urokinase into an antibody-recruiting anticancer agent |
ES2905359T3 (es) | 2012-04-26 | 2022-04-08 | Univ Yale | Moléculas de suministro de fármacos citotóxicos dirigidas al VIH (CDM-H), actividad citotóxica contra el virus de la inmunodeficiencia humana y métodos de uso |
WO2013166110A1 (en) | 2012-05-02 | 2013-11-07 | Yale University | Tlr-agonist-conjugated antibody recruiting molecules (tlr_arms) |
JP6473138B2 (ja) | 2013-05-03 | 2019-02-20 | イェール ユニバーシティーYale University | 癌、特に前立腺癌を標的とする合成抗体模倣化合物(SyAM) |
WO2016105527A1 (en) | 2014-12-23 | 2016-06-30 | Tobira Therapeutics, Inc. | Process of making cenicriviroc and related analogs |
WO2017023994A1 (en) | 2015-08-06 | 2017-02-09 | Yale University | Small molecule based antibody-recruiting compounds for cancer treatment |
PL3390441T3 (pl) | 2015-12-15 | 2022-01-10 | Gilead Sciences, Inc. | Przeciwciała neutralizujące ludzki wirus niedoboru odporności |
AU2017235571B2 (en) * | 2016-03-18 | 2024-05-16 | Georgetown University | Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moieties |
BR112018076449A2 (pt) | 2016-06-21 | 2019-04-09 | Tobira Therapeutics, Inc. | cenicriviroc purificado e intermediários purificados para fazer cenicriviroc |
US10780084B2 (en) | 2016-08-03 | 2020-09-22 | Yale University | Antibody-recruiting molecules for the treatment of cancer |
CA3034606A1 (en) | 2016-08-31 | 2018-03-08 | Tobira Therapeutics, Inc. | Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate |
CN107056762B (zh) * | 2016-12-22 | 2020-08-28 | 四川百利药业有限责任公司 | 一种用作抗流感病毒的双羰基类似物 |
JP7009517B2 (ja) | 2017-06-21 | 2022-01-25 | ギリアード サイエンシーズ, インコーポレイテッド | Hiv gp120およびcd3を標的とする多重特異性抗体 |
CN113197912B (zh) * | 2020-01-30 | 2023-02-03 | 沈阳福洋医药科技有限公司 | 异戊酰螺旋霉素类化合物及其组合物在制备抗病毒药物中的应用 |
CN111995622B (zh) * | 2020-08-20 | 2022-04-15 | 复旦大学 | 化合物及其用途 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
ZA893284B (en) * | 1988-05-04 | 1990-03-28 | Igen Inc | Peptide analogs and their use as haptens to elicit catalytic antibodies |
EP0646019B9 (en) * | 1992-06-09 | 2002-12-18 | Neorx Corporation | Biotin-DOTA conjugates and their use in pretargeting methods |
JP3319073B2 (ja) * | 1993-08-24 | 2002-08-26 | 和光純薬工業株式会社 | 免疫学的測定方法 |
US6140505A (en) * | 1995-03-10 | 2000-10-31 | G. D. Searle & Co. | Synthesis of benzo fused heterocyclic sulfonyl chlorides |
US6469006B1 (en) * | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
US6573262B2 (en) * | 2000-07-10 | 2003-06-03 | Bristol-Myers Sqibb Company | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
JP2004502768A (ja) * | 2000-07-10 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | 置換インドールオキソアセチックピペラジン誘導体の組成物と抗ウイルス活性 |
US6825201B2 (en) * | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
HUP0401523A3 (en) * | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
ES2663080T3 (es) * | 2006-11-01 | 2018-04-11 | Ventana Medical Systems, Inc. | Haptenos, conjugados de haptenos, composiciones de los mismos y método para su preparación y uso |
PL2291659T3 (pl) | 2008-05-13 | 2016-04-29 | Univ Yale | Małe cząsteczki chimerowe do rekrutacji przeciwciał do komórek nowotworowych |
WO2010008519A2 (en) * | 2008-07-14 | 2010-01-21 | Andrew Metters | In vitro diagnostic markers comprising carbon nanoparticles and kits |
EP2395992A2 (en) * | 2009-02-10 | 2011-12-21 | The Scripps Research Institute | Chemically programmed vaccination |
WO2011046946A2 (en) | 2009-10-13 | 2011-04-21 | Yale University | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
EP2601174B1 (en) * | 2010-08-06 | 2014-11-26 | Bristol-Myers Squibb Company | Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
SG10201510402WA (en) | 2010-11-18 | 2016-01-28 | Univ Yale | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
-
2011
- 2011-11-17 SG SG10201510402WA patent/SG10201510402WA/en unknown
- 2011-11-17 SG SG2013038344A patent/SG190829A1/en unknown
- 2011-11-17 AU AU2011329829A patent/AU2011329829B2/en active Active
- 2011-11-17 EA EA201390726A patent/EA201390726A1/ru unknown
- 2011-11-17 MX MX2013005462A patent/MX350974B/es active IP Right Grant
- 2011-11-17 KR KR1020137015098A patent/KR20140000275A/ko not_active Application Discontinuation
- 2011-11-17 PE PE2013001206A patent/PE20140406A1/es not_active Application Discontinuation
- 2011-11-17 US US13/988,251 patent/US9562038B2/en active Active
- 2011-11-17 JP JP2013540011A patent/JP6155193B2/ja active Active
- 2011-11-17 EP EP11842404.3A patent/EP2640720B1/en active Active
- 2011-11-17 CA CA2818308A patent/CA2818308A1/en not_active Abandoned
- 2011-11-17 BR BR112013012309A patent/BR112013012309A2/pt not_active Application Discontinuation
- 2011-11-17 CN CN201611167953.2A patent/CN107011333B/zh active Active
- 2011-11-17 WO PCT/US2011/061174 patent/WO2012068366A2/en active Application Filing
- 2011-11-17 CN CN201180065404.3A patent/CN103402998B/zh active Active
-
2013
- 2013-05-16 IL IL226397A patent/IL226397B/en active IP Right Grant
- 2013-05-17 CL CL2013001429A patent/CL2013001429A1/es unknown
- 2013-06-07 CO CO13138546A patent/CO6801635A2/es not_active Application Discontinuation
-
2016
- 2016-11-04 JP JP2016215788A patent/JP6567486B2/ja active Active
- 2016-12-15 US US15/379,969 patent/US10030008B2/en active Active
-
2018
- 2018-07-17 US US16/037,678 patent/US10703743B2/en active Active
-
2020
- 2020-06-05 US US16/894,362 patent/US11136316B2/en active Active
-
2021
- 2021-09-09 US US17/470,393 patent/US11858917B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20140406A1 (es) | Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humana | |
MX2020004504A (es) | Derivados de fenoximetilo. | |
EA201791359A1 (ru) | Конъюгаты, связывающие белок-лекарственное средство, содержащие производные антрациклина | |
EA201691272A1 (ru) | Тетрагидропиридопиразины в качестве модуляторов gpr6 | |
MD3464249T2 (ro) | Derivați carbonucleozidici substituiţi utili în calitate de agenți anticanceroşi | |
EA201591632A1 (ru) | Цитотоксические и антимитотические соединения и способы их применения | |
EA201591497A1 (ru) | Новые производные октагидропирроло[3,4-c]пиррола и их аналоги в качестве ингибиторов аутотаксина | |
EA201492223A1 (ru) | Новые диазаспироциклоалканы и азаспироциклоалканы | |
MY169043A (en) | New dihydroquinoline-2-one derivatives | |
EA201001205A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
EA201100299A1 (ru) | Органические соединения | |
EA201170772A1 (ru) | Органические соединения | |
EA200901612A1 (ru) | Противовоспалительные соединения замещенных циклобутендионов | |
MY153915A (en) | Organic compounds | |
PH12016502358B1 (en) | Novel pyrrolidine compound and application as melanocortin receptor agonist | |
MY169267A (en) | New aryl-quinoline derivatives | |
CY1122441T1 (el) | Καινοτομες ενωσεις και συζευγματα κρυπτοφυκινης, η παρασκευη τους και η θεραπευτικη χρηση τους | |
EA201691982A1 (ru) | 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов | |
MX364069B (es) | Moduladores de la proteína activadora de 5-lipoxigenasa. | |
MX2015001099A (es) | Nuevos derivados biciclicos de piridina. | |
EA201270256A1 (ru) | Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида | |
EA201190293A1 (ru) | Пролекарства триптолида | |
BR112016002638A2 (pt) | novos aza-oxo-indóis para o tratamento e profilaxia de infecção pelo virus sincicial respiratório | |
EA201792425A1 (ru) | Трициклические соединения и их применение в качестве ингибиторов фосфодиэстераз |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |